In this episode, Drs. Erin Michos and Leslie Cho discuss the research presented at ACC.24 related to statin intolerance and bempedoic acid. Dr. Cho’s research publication “Characteristics and Outcomes for Statin Intolerant Women Receiving Bempedoic Acid in The Clear Outcomes Trial” is discussed, as well as lipid management for women, Hispanic, Latinx, and obese patients in the CLEAR Outcomes Trial.

This podcast is part of Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative. 

Educational grant support is provided by Esperion. 

Related References:

1. Cho L, Plutzky J, Brennan D, et al. Characteristics and outcomes for statin-intolerant women receiving bempedoic acid in the CLEAR OUTCOMES trial. J Am Coll Cardiol 2024;83:1751.
2. Rodriguez F, Brennan D, Lei L, Nissen SE, Powell H, Plutzky J. Characteristics and outcomes for statin-intolerant Hispanic/Lantinx women receiving bempedoic acid: results from a CLEAR OUTCOMES pre-specified subanalysis. J Am Coll Cardiol 2024;83:1811.
3. Bays HE, Bloedon L, Brennan D, et al. Bempedoic acid and cardiovascular disease outcomes in patients with obesity: a CLEAR OUTCOMES subset analysis. J Am Coll Cardiol 2024;83:1967.
4. Nissen SE, Menon V, Nicholls SJ, et al. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA 2023;330:131-140.